Alumis (ALMS) Accounts Payables (2023 - 2026)
Alumis (ALMS) posted quarterly Accounts Payables of $10.1 million for Q4 2025, up 5.01% year-over-year from $9.6 million in Q4 2024, and up 121.91% quarter-over-quarter from $4.6 million in Q3 2025.
Alumis (ALMS) Accounts Payables (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Accounts Payables for 3 consecutive years, with $10.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables rose 5.01% year-over-year to $10.1 million; the TTM figure through Dec 2025 stood at $10.1 million (up 5.01% YoY), while the FY2025 annual figure was $10.1 million, up 5.01% from the prior year.
- Accounts Payables grew to $10.1 million in Q4 2025 per ALMS's latest filing, from $4.6 million in the prior quarter.
- Across five years, Accounts Payables topped out at $15.0 million in Q2 2025 and bottomed at $1.1 million in Q4 2023.
- Historically, Accounts Payables has averaged $7.9 million across 3 years, with a median of $8.3 million in 2024.
- Annual changes were most pronounced in 2024 — Accounts Payables jumped 760.82% — and 2025, when it slipped 29.33%.
- Alumis' Accounts Payables stood at $1.1 million in 2023, then surged by 760.82% to $9.6 million in 2024, then climbed by 5.01% to $10.1 million in 2025.
- Business Quant data shows ALMS's Accounts Payables at $10.1 million in Q4 2025, $4.6 million in Q3 2025, and $15.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | 12.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.80 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 14.98 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 9.19 Mn |
| Dec 31, 2023 | 1.12 Mn |